Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort
- PMID: 20837893
- DOI: 10.1161/CIRCULATIONAHA.110.948877
Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort
Abstract
Background: Although short- and medium-term outcomes after transcatheter aortic valve implantation are encouraging, long-term data on valve function and clinical outcomes are limited.
Methods and results: Consecutive high-risk patients who had been declined as surgical candidates because of comorbidities but who underwent successful transcatheter aortic valve implantation with a balloon-expandable valve between January 2005 and December 2006 and survived past 30 days were assessed. Clinical, echocardiographic, and computed tomographic follow-up examinations were performed. Seventy patients who underwent successful procedures and survived longer than 30 days were evaluated at a minimum follow-up of 3 years. At a median follow-up of 3.7 years (interquartile range 3.4 to 4.3 years), survival was 57%. Survival at 1, 2, and 3 years was 81%, 74%, and 61%, respectively. Freedom from reoperation was 98.5% (1 patient with endocarditis). During this early procedural experience, 11 patients died within 30 days, and 8 procedures were unsuccessful. When these patients were included, overall survival was 51%. Transaortic pressure gradients increased from 10.0 mm Hg (interquartile range 8.0 to 12.0 mm Hg) immediately after the procedure to 12.1 mm Hg (interquartile range 8.6 to 16.0 mm Hg) after 3 years (P=0.03). Bioprosthetic valve area decreased from a mean of 1.7±0.4 cm(2) after the procedure to 1.4±0.3 cm(2) after 3 years (P<0.01). Aortic incompetence after implantation was trivial or mild in 84% of cases and remained unchanged or improved over time. There were no cases of structural valvular deterioration, stent fracture, deformation, or valve migration.
Conclusions: Transcatheter aortic valve implantation demonstrates good medium- to long-term durability and preserved hemodynamic function, with no evidence of structural failure. The procedure appears to offer an adequate and lasting resolution of aortic stenosis in selected patients.
Comment in
-
Valvular disease: TAVI shown to be effective and durable.Nat Rev Cardiol. 2010 Dec;7(12):663. doi: 10.1038/nrcardio.2010.167. Nat Rev Cardiol. 2010. PMID: 21155125 No abstract available.
Similar articles
-
Transcatheter aortic valve implantation: anesthetic considerations.Anesth Analg. 2009 May;108(5):1453-62. doi: 10.1213/ane.0b013e31819b07ce. Anesth Analg. 2009. PMID: 19372319 Review.
-
Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team.Eur J Cardiothorac Surg. 2009 Apr;35(4):615-20; discussion 620-1. doi: 10.1016/j.ejcts.2008.12.041. Epub 2009 Feb 23. Eur J Cardiothorac Surg. 2009. PMID: 19233669
-
Clinical experience with the second-generation 3f Enable sutureless aortic valve prosthesis.J Thorac Cardiovasc Surg. 2010 Aug;140(2):313-6. doi: 10.1016/j.jtcvs.2009.10.041. J Thorac Cardiovasc Surg. 2010. PMID: 20637916 Clinical Trial.
-
Outcomes of off-pump aortic valve bypass surgery for the relief of aortic stenosis in adults.Ann Thorac Surg. 2011 Jan;91(1):131-6. doi: 10.1016/j.athoracsur.2010.10.074. Ann Thorac Surg. 2011. PMID: 21172501
-
Transcatheter aortic valve implantation: the state of play.Future Cardiol. 2010 Mar;6(2):243-54. doi: 10.2217/fca.10.3. Future Cardiol. 2010. PMID: 20230265 Review.
Cited by
-
Inflammatory Status Assessment by Machine Learning Techniques to Predict Outcomes in Patients with Symptomatic Aortic Stenosis Treated by Transcatheter Aortic Valve Replacement.Diagnostics (Basel). 2023 Sep 11;13(18):2907. doi: 10.3390/diagnostics13182907. Diagnostics (Basel). 2023. PMID: 37761276 Free PMC article.
-
Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study.PLoS One. 2023 Mar 16;18(3):e0282636. doi: 10.1371/journal.pone.0282636. eCollection 2023. PLoS One. 2023. PMID: 36928217 Free PMC article.
-
Flow dynamics of surgical and transcatheter aortic valves: Past to present.JTCVS Open. 2022 Jan 24;9:43-56. doi: 10.1016/j.xjon.2022.01.017. eCollection 2022 Mar. JTCVS Open. 2022. PMID: 36003460 Free PMC article.
-
Towards Longitudinal Monitoring of Leaflet Mobility in Prosthetic Aortic Valves via In-Situ Pressure Sensors: In-Silico Modeling and Analysis.Cardiovasc Eng Technol. 2023 Feb;14(1):25-36. doi: 10.1007/s13239-022-00635-1. Epub 2022 Jun 6. Cardiovasc Eng Technol. 2023. PMID: 35668222
-
Rare Cause of Severe Mitral Regurgitation after TAVI: Case Report and Literature Review.Medicina (Kaunas). 2022 Mar 23;58(4):464. doi: 10.3390/medicina58040464. Medicina (Kaunas). 2022. PMID: 35454303 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous